The CEO of French consumer goods giant Danone on Wednesday downplayed the threat of obesity drugs on its food business. Antoine de Saint-Affrique told CNBC that surging demand for drugs like Wegovy ...

NEW YORK, Aug 11 (Reuters) - Danone (DANO.PA), opens new tab is introducing an Oikos brand drink targeting U.S. consumers using weight loss medications such as Wegovy, pledging the dairy-based ...

Danone has confirmed earlier estimates on the cost of its infant formula recall. In January 2026, Danone announced a recall ...

Protein and functional hydration fuelled Danone’s Q1 FY26 growth, helping offset an infant formula recall and weak consumer sentiment.

Danone plans to double down on health and nutrition in the coming years as food companies seek to tackle the effects of Ozempic and other blockbuster weight-loss drugs on eating habits. Two years into ...

As the early signs of GLP-1-driven disruption emerge in the food sector, more manufacturers are exploring weight management-friendly innovation. The shift isn’t seismic yet, but momentum is building.

Danone and Nutri-Score’s relationship wasn’t always sour. When the nutrition labelling scheme first entered the market, Danone was among the first adopters. Soon, Danone was rallying for the mandatory ...

The conflict in the Middle East is presenting Danone SA with supply chain challenges and cost inflation pressures, in ...